48 related articles for article (PubMed ID: 23176654)
21. Vaccine stabilization: research, commercialization, and potential impact.
Kristensen D; Chen D; Cummings R
Vaccine; 2011 Sep; 29(41):7122-4. PubMed ID: 21651941
[TBL] [Abstract][Full Text] [Related]
22. Spray drying and vaccine stabilization.
McAdams D; Chen D; Kristensen D
Expert Rev Vaccines; 2012 Oct; 11(10):1211-9. PubMed ID: 23176654
[TBL] [Abstract][Full Text] [Related]
23. Developments in the formulation and delivery of spray dried vaccines.
Kanojia G; Have RT; Soema PC; Frijlink H; Amorij JP; Kersten G
Hum Vaccin Immunother; 2017 Oct; 13(10):2364-2378. PubMed ID: 28925794
[TBL] [Abstract][Full Text] [Related]
24. Spray drying technique: II. Current applications in pharmaceutical technology.
Sollohub K; Cal K
J Pharm Sci; 2010 Feb; 99(2):587-97. PubMed ID: 19862804
[TBL] [Abstract][Full Text] [Related]
25. Stability of lyophilized and spray dried vaccine formulations.
Preston KB; Randolph TW
Adv Drug Deliv Rev; 2021 Apr; 171():50-61. PubMed ID: 33484735
[TBL] [Abstract][Full Text] [Related]
26. Vaccine process technology.
Josefsberg JO; Buckland B
Biotechnol Bioeng; 2012 Jun; 109(6):1443-60. PubMed ID: 22407777
[TBL] [Abstract][Full Text] [Related]
27. Spray drying of pharmaceuticals and biopharmaceuticals: Critical parameters and experimental process optimization approaches.
Ziaee A; Albadarin AB; Padrela L; Femmer T; O'Reilly E; Walker G
Eur J Pharm Sci; 2019 Jan; 127():300-318. PubMed ID: 30428336
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary vaccine delivery.
Lu D; Hickey AJ
Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
[TBL] [Abstract][Full Text] [Related]
29. The Vaccine Formulation Laboratory: a platform for access to adjuvants.
Collin N; Dubois PM
Vaccine; 2011 Jul; 29 Suppl 1():A37-9. PubMed ID: 21684427
[TBL] [Abstract][Full Text] [Related]
30. Drying technology strategies for colon-targeted oral delivery of biopharmaceuticals.
Vass P; Démuth B; Hirsch E; Nagy B; Andersen SK; Vigh T; Verreck G; Csontos I; Nagy ZK; Marosi G
J Control Release; 2019 Feb; 296():162-178. PubMed ID: 30677436
[TBL] [Abstract][Full Text] [Related]
31. Vaccine presentations and delivery technologies--what does the future hold?
Clements CJ; Wesselingh SL
Expert Rev Vaccines; 2005 Jun; 4(3):281-7. PubMed ID: 16026244
[TBL] [Abstract][Full Text] [Related]
32. [The use of spray drying in pharmacy (author's transl)].
Kala H; Traue J; Moldenhauer H; Zessin G
Pharmazie; 1979 Dec; 34(12):779-84. PubMed ID: 397493
[TBL] [Abstract][Full Text] [Related]
33. [The way to long-term ambient temperature stabilization of biologicals--freeze-drying and evaporative-drying with vitrification].
Franks F; Terashima M
Tanpakushitsu Kakusan Koso; 1996 May; 41(6):810-6. PubMed ID: 8787051
[No Abstract] [Full Text] [Related]
34. Thermal stability of vaccines.
Brandau DT; Jones LS; Wiethoff CM; Rexroad J; Middaugh CR
J Pharm Sci; 2003 Feb; 92(2):218-31. PubMed ID: 12532371
[TBL] [Abstract][Full Text] [Related]
35. A review on current downstream bio-processing technology of vaccine products.
Li M; Qiu YX
Vaccine; 2013 Feb; 31(9):1264-7. PubMed ID: 23313813
[TBL] [Abstract][Full Text] [Related]
36. DNA vaccine manufacture: scale and quality.
Cai Y; Rodriguez S; Hebel H
Expert Rev Vaccines; 2009 Sep; 8(9):1277-91. PubMed ID: 19722898
[TBL] [Abstract][Full Text] [Related]
37. Particle engineering techniques for inhaled biopharmaceuticals.
Shoyele SA; Cawthorne S
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1009-29. PubMed ID: 17005293
[TBL] [Abstract][Full Text] [Related]
38. Analysis of vaccine stability.
Volkin DB; Burke CJ; Sanyal G; Middaugh CR
Dev Biol Stand; 1996; 87():135-42. PubMed ID: 8854010
[TBL] [Abstract][Full Text] [Related]
39. Stabilizing vaccines via drying: Quality by design considerations.
Ghaemmaghamian Z; Zarghami R; Walker G; O'Reilly E; Ziaee A
Adv Drug Deliv Rev; 2022 Aug; 187():114313. PubMed ID: 35597307
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
